All Stories

  1. HIV Infection a Social and a Healthcare Problem
  2. OPPORTUNISTIC PATHOGENS IN PATIENTS WITH URINARY TRACT INFECTION
  3. Opportunistic Pathogens in Patients with Urinary Tract Infection
  4. Opportunistic Pathogens in Patients with Urinary Tract Infection
  5. Laboratory Methods in the Screening of Viral C Hepatitis
  6. Disinfectants
  7. Microbial Contamination in Water Systems
  8. Editorial Comment
  9. Assessment of airborne endotoxin in sandstorm dust and indoor environments using a novel passive sampling device in Al Zulfi city, Saudi Arabia – Establishing threshold exposure levels
  10. Virulence profiles of some Pseudomonas aeruginosa clinical isolates and their association with the suppression of Candida growth in polymicrobial infections
  11. Potential Drugs for Treating COVID-19 Infection
  12. Significant help
  13. Study of contact plates recovery from pharmaceutical cleanroom surfaces across three-time ranges
  14. Robust infection prevention
  15. Review of the efficacy of HEPA filtered air to control coronavirus risks in cleanrooms
  16. Antimicrobial Activity of Silver-Treated Bacteria against other Multi-Drug Resistant Pathogens in Their Environment
  17. Assessing Gram-stain error rates within the pharmaceutical microbiology laboratory
  18. COVID-19 and dental practice
  19. Utilities Design and Testing
  20. Use of Hazard Analysis Critical Control Point (HACCP) methodology for biocontamination control: Assessing microbial risks and to determining environmental monitoring locations
  21. A novel mechanism of action of ketoconazole: inhibition of the NorA efflux pump system and biofilm formation in multidrug-resistant Staphylococcus aureus
  22. Particle Counting
  23. Cleanroom Microbiota
  24. Biocontamination Deviation Management
  25. Assessment of Pharmaceutical Water Systems
  26. Bioburden and Endotoxin Control in Pharmaceutical Processing
  27. Biocontamination Control Strategy
  28. Cleanrooms and Environmental Monitoring
  29. Data Handling and Trend Analysis
  30. Designing and Implementing an Environmental Monitoring Program
  31. GMP, Regulations and Standards
  32. Introduction to Biocontamination and Biocontamination Control
  33. Rapid and Alterative Microbiological Methods
  34. Risk Assessment and Investigation for Environmental Monitoring
  35. Selection and Application of Culture Media
  36. Sources of Microbial Contamination and Risk Profiling
  37. Special Types of Environmental Monitoring
  38. The Human Factor and Biocontamination Control
  39. Viable Environmental Monitoring Methods
  40. Disinfectants and Biocides
  41. A review on biocide reduced susceptibility due to plasmid-borne antiseptic-resistant genes-special notes on pharmaceutical environmental isolates
  42. Distribution of biocide resistant genes and biocides susceptibility in multidrug-resistant Klebsiella pneumoniae , Pseudomonas aeruginosa and Acinetobacter baumannii — A first report from the Kingdom of Saudi Arabia
  43. Microbiological Test Data—Assuring Data Integrity
  44. Cleaning and disinfection of dental practice surfaces
  45. A study of airborne fungal allergens in sandstorm dust in Al-Zulfi, Central region of Saudi Arabia
  46. Chapter 7 Clean room design principles
  47. Evaluation of quaternary ammonium compound disinfectants against mycobacteria in dental practices
  48. A review of melanized (black) fungal contamination in pharmaceutical products-incidence, drug recall and control measures
  49. Bacteriophages offer an Antimicrobial Solution
  50. Manufacturing and validation
  51. Microbial identification
  52. Biological indicators
  53. Microbiological data
  54. Bioburden determination
  55. Introduction
  56. Auditing the microbiology laboratory
  57. Introduction to pharmaceutical microbiology
  58. Microbiological challenges to the pharmaceuticals and healthcare
  59. Endotoxin and pyrogen testing
  60. Microbiological culture media
  61. Sterilization and sterility assurance
  62. Microbiology and pharmaceuticals
  63. Cleanrooms and environmental monitoring
  64. Laboratory management and design
  65. Antibiotics and preservatives
  66. GMP and regulations
  67. Rapid microbiological methods
  68. Risk assessment and microbiology
  69. Specified and objectionable microorganisms
  70. Cleaning and disinfection
  71. Microbiology laboratory techniques
  72. Assessment of pharmaceutical water systems
  73. Determination of Minimum inhibitory concentrations of Common Biocides to Multidrug-Resistant Gram-negative bacteria
  74. Pharmaceutical Microbiology
  75. Advances in Rapid Pathogen Detection
  76. Characterizing the Microbiota of a Pharmaceutical Water System-A Metadata Study
  77. Evaluating biocides to kill fungi
  78. Teixobactin: A New Class of Antibiotic
  79. In vitro fungicidal activity of biocides against pharmaceutical environmental fungal isolates
  80. Rapid microbiological methods for cleanroom environments
  81. Interview: Pharmaceutical microbiology
  82. Trichoderma
  83. FUNGI | Classification of the Peronosporomycetes
  84. Laboratory Design
  85. BIOCHEMICAL AND MODERN IDENTIFICATION TECHNIQUES | Enterobacteriaceae, Coliforms, and Escherichia Coli
  86. BIOCHEMICAL AND MODERN IDENTIFICATION TECHNIQUES | Food-Poisoning Microorganisms
  87. Novel Methods to Address Antimicrobial Resistance
  88. The Possible Origins of Tuberculosis in South America
  89. Comparative Evaluation of Traditional Susceptibility Testing for MRSA with the PCR Approach
  90. Comparison of Different Fungal Agar for the Environmental Monitoring of Pharmaceutical-Grade Cleanrooms
  91. Sterility, sterilisation and sterility assurance for pharmaceuticals
  92. Preface
  93. Introduction
  94. Sterility, sterilisation and microorganisms
  95. Pyrogenicity and bacterial endotoxin
  96. Gamma radiation
  97. Electron beam processing
  98. Dry heat sterilisation
  99. Steam sterilisation
  100. Gaseous sterilisation
  101. Hydrogen peroxide vapour sterilisation
  102. Sterilisation by filtration
  103. Other methods of sterilisation
  104. Media simulation trials
  105. Aseptic processing and filling
  106. Depyrogenation and endotoxin
  107. Biological indicators
  108. Regulatory requirements and Good Manufacturing Practices (GMP)
  109. Investigating sterility test failures
  110. The Sterility Test
  111. Cleanrooms, isolators and cleanroom technology
  112. Cleaning and disinfection of sterile processing facilities
  113. Auditing sterilisation processes and facilities
  114. Pharaohs and Mummies: Diseases of Ancient Egypt and Modern Approaches
  115. Global Strategies for Elimination of Leprosy: A Review of Current Progress
  116. Could the ‘Black Death’ Become a Re-Emerging Infectious Disease?
  117. Study of psychrophilic and psychrotolerant micro-organisms isolated in cold rooms used for pharmaceutical processing
  118. Application of Quality Risk Management To Set Viable Environmental Monitoring Frequencies in Biotechnology Processing and Support Areas
  119. In vitro Antifungal Efficacy of Biguanides and Quaternary Ammonium Compounds against Cleanroom Fungal Isolates
  120. Some considerations for the implementation of disposable technology and single-use systems in biopharmaceuticals
  121. Some considerations for the implementation of disposable technology and single-use systems in biopharmaceuticals
  122. A Review of Cleanroom Microflora: Types, Trends, and Patterns